TIS 0.00% 0.0¢ tissue therapies limited

12 month price target, page-22

  1. 426 Posts.
    I personally don't think the EU trials will have much of an impact on the SP. At least they shouldn't as any investor who has read into the product and previous trials will have full confidence that it will be a success.
    Any movement on them I would see as a reactionary move by traders, and prone to a retrace.

    The big milestones over the coming years for me would be
    - Partnership - Early 2011
    - EU Commercial Sales - Late 2011
    - Dividend Payment - 2012?
    - US FDA - ??
    - US Commercial Sales - ??
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.